Comparison of Insulin Glargine Against Insulin Aspart Infused Under the Skin in Patients With Type 2 Diabetes

Mise à jour : Il y a 4 ans
Référence : NCT00184613

Femme et Homme

  • | Pays :
  • Denmark
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

This trial is conducted in Europe. The objective of the study is to investigate the effect and safety of continously basal delivered insulin aspart given by a pump versus once daily injection of insulin glargine.


Critère d'inclusion

  • diabetes ,Diabetes Mellitus, Type 2 ,Delivery Systems

Liens